Category: Federal False Claims Act
On October 3, 2011, counsel for whistleblower and qui tam Plaintiff Beatrice Maitland announced the settlement of False Claims Act allegations against a subsidiary of Select Medical Corporation for suspect “Medical Director” payments made to various physicians. Specifically, Select Specialty Hospital–Columbus, Inc. agreed to pay $7.5 million to settle claims that it submitted claims to Medicare for reimbursement based on illegal referral fee agreements between certain Select Medical Corporation hospitals and physicians who were “Medical Directors” at the hospitals that amounted to kickbacks,
On Friday September 30, 2011, the U.S. Department of Justice announced that home health provider LHC Group, Inc. (“LHC”) had agreed to pay $65 million to settle a suit brought under the False Claims Act alleging that the company charged the government for visits to Medicaid, the Federal Employees Health Benefits programs,
Both the SEC and the Department of Justice are investigating whether Motorola bribed European officials in exchange for business. The investigation resulted from Motorola’s own internal investigation of suspicious transactions within Turkey, which was reported to United States authorities. The probe expanded to Motorola’s transactions in Europe involving a lobbyist previously investigated for bribery.
The SEC has filed a civil complaint against Corey Ribotsky and his hedge fund, NIR Group of fraud by concealing losses and using investor funds for personal expenses. The Complaint alleges that Ribotsky misappropriated over $1 million in client funds and using the funds for automobile payments and jewelry. The complaint also alleges that the hedge fund never generated sufficient cash to pay investors,
A federal district court has ruled that in order to bring a claim for retaliation under the Dodd-Frank Act’s securities whistleblower retaliation provisions, the purported whistleblower must submit information to the Securities and Exchange Commission. In Egan v. Tradingscreen, Inc., (No. 10 Civ. 8202, (S.D.N.Y., May 4,
A wholly owned subsidiary of Boston Scientific agreed to pay $9.25 million to the U.S. to settle False Claims Act allegations that it overcharged federal health programs for replacement pacemakers and defibrillators.
According to allegations in a qui tam suit filed by whistleblower Robert A. Fry,
Abri Health Plan Inc., of Germantown Wisconsin and its parent company, Universal American Financial Corp., agreed to pay $4.8 million to the U.S. to resolve a suit brought under the qui tam provisions of the False Claims Act relating to its Medicare Part C coverage plan.
According to the whistleblowers,
On September 27, 2011, Stephen H. Stern, a Kentucky physician, and his practice, Kentuckiana Center for Better Bone and Joint Health, agreed to pay $349,860 to the U.S. to settle claims that Stern double billed Medicare for a drug used to treat arthritis. The settlement arose from a qui tam complaint filed by Suzette L.
The article “Why is Qui Tam Litigation Often So Difficult to Resolve?” was authored by Marc S. Raspanti, Esq. and Meredith Auten, Esq. and featured in the September 2011 edition of AHLA Connections. Mr. Raspanti is founder of the firm’s Qui Tam Litigation Practice Group.
https://www.falseclaimsact.com/wp-content/uploads/2013/02/feature_sept20111.pdf
Lydia Demski, the owner and founder of several companies, agreed to pay $800,000 to the U.S. to resolve False Claims Act allegations that a company she owned fraudulently obtained a service-disabled veteran-owned small-business (SD VOSB) contract to refurbish equipment at a NASA facility in Ohio. Demski who is not a service-disabled veteran,
